Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1984 Oct;26(4):513–518. doi: 10.1128/aac.26.4.513

Pharmacokinetics of cefotiam administered intravenously and intramuscularly to healthy adults.

A M Brisson, A Bryskier, L Millerioux, J B Fourtillan
PMCID: PMC179955  PMID: 6097166

Abstract

We studied the pharmacokinetics of cefotiam, a parenteral cephalosporin, at intravenous doses of 0.5, 1, and 2 g and intramuscular doses of 0.5 and 1 g in two groups of eight healthy adult volunteers. The concentrations of cefotiam in plasma were determined over a period of 5 or 6 h and in urine over 24 h, using high-pressure liquid chromatographic procedures. Plasma concentration-time data were fitted to a three-exponential equation for the intravenous administration, and after intramuscular administration, the data were analyzed by a two-compartment or a one-compartment open model. Over the above dosing range and routes of administration, cefotiam pharmacokinetics were essentially linear, with plasma clearances varying from 19.6 to 22.5 liters/h. No significant differences were observed with respect to the terminal half-life (1 h) and the area under the curve versus the dose. Intramuscularly injected cefotiam was 63 to 74% available. The fraction of dose excreted unchanged in urine (0.50 to 0.67) indicated a substantial nonrenal mechanism of elimination. The apparent volume of distribution (about 30 liters) was higher than those of other parenteral cephalosporins.

Full text

PDF
513

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barriere S. L., Hatheway G. J., Gambertoglio J. G., Lin E. T., Conte J. E., Jr Pharmacokinetics of cefonicid, a new broad-spectrum cephalosporin. Antimicrob Agents Chemother. 1982 Jun;21(6):935–938. doi: 10.1128/aac.21.6.935. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bergan T. Comparative pharmacokinetics of cefazolin, cephalothin, cephacetril, and cephapirine after intravenous administration. Chemotherapy. 1977;23(6):389–404. doi: 10.1159/000222009. [DOI] [PubMed] [Google Scholar]
  3. Bodey G. P., Fainstein V., Hinkle A. M. Comparative in vitro study in new cephalosporins. Antimicrob Agents Chemother. 1981 Aug;20(2):226–230. doi: 10.1128/aac.20.2.226. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brisson A. M., Fourtillan J. B. Pharmacokinetic study of cefadroxil following single and repeated doses. J Antimicrob Chemother. 1982 Sep;10 (Suppl B):11–15. doi: 10.1093/jac/10.suppl_b.11. [DOI] [PubMed] [Google Scholar]
  5. Daschner F. D., Hemmer K. A., Offermann P., Slanicka J. Pharmacokinetics of cefotiam in normal humans. Antimicrob Agents Chemother. 1982 Dec;22(6):958–960. doi: 10.1128/aac.22.6.958. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Fourtillan J. B., Brisson A. M. Pharmacocinétique comparée de moxalactam et d'autres céphalosporines. Sem Hop. 1983 Jun 30;59(26):1968–1971. [PubMed] [Google Scholar]
  7. Gomeni C., Gomeni R. IGPHARM: interactive graphic package for pharmacokinetic analysis. Comput Biomed Res. 1978 Aug;11(4):345–361. doi: 10.1016/0010-4809(78)90017-4. [DOI] [PubMed] [Google Scholar]
  8. Griffith R. S., Black H. R., Brier G. L., Wolny J. D. Cefamandole: in vitro and clinical pharmacokinetics. Antimicrob Agents Chemother. 1976 Nov;10(5):814–823. doi: 10.1128/aac.10.5.814. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kemmerich B., Lode H., Belmega G., Jendroschek T., Borner K., Koeppe P. Comparative pharmacokinetics of cefoperazone, cefotaxime, and moxalactam. Antimicrob Agents Chemother. 1983 Mar;23(3):429–434. doi: 10.1128/aac.23.3.429. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Lüthy R., Münch R., Blaser J., Bhend H., Siegenthaler W. Human pharmacology of cefotaxime (HR 756), a new cephalosporin. Antimicrob Agents Chemother. 1979 Aug;16(2):127–133. doi: 10.1128/aac.16.2.127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Patel I. H., Weinfeld R. E., Konikoff J., Parsonnet M. Pharmacokinetics and tolerance of ceftriaxone in humans after single-dose intramuscular administration in water and lidocaine diluents. Antimicrob Agents Chemother. 1982 Jun;21(6):957–962. doi: 10.1128/aac.21.6.957. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Peterson L. R., Gerding D. N., Van Etta L. L., Eckfeldt J. H., Larson T. A. Pharmacokinetics, protein binding, and extravascular distribution of ceftizoxime in normal subjects. Antimicrob Agents Chemother. 1982 Nov;22(5):878–881. doi: 10.1128/aac.22.5.878. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Satake K., Cho K., Taniura M., Oka I., Koo I. Cefotiam concentrations in bile and in the wall of the gallbladder in patients with biliary disease. J Antimicrob Chemother. 1982 Aug;10(2):141–145. doi: 10.1093/jac/10.2.141. [DOI] [PubMed] [Google Scholar]
  14. Tsuchiya K., Kida M., Kondo M., Ono H., Takeuchi M., Nishi T. SCE-963, a new broad-spectrum cephalosporin: in vitro and in vivo antibacterial activities. Antimicrob Agents Chemother. 1978 Oct;14(4):557–568. doi: 10.1128/aac.14.4.557. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES